BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38010835)

  • 1. High-Fidelity Identification of Single Nucleotide Polymorphism by Type V CRISPR Systems.
    He Y; Shao S; Chen J
    ACS Sens; 2023 Dec; 8(12):4478-4483. PubMed ID: 38010835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dual identification strategy based on padlock ligation and CRISPR/Cas14a for highly specific detection of BRAF V600E mutation in clinical samples.
    Shi W; Gong Y; Zhang D; Yang T; Yi M; Tan J; Ding S; Cheng W
    Anal Methods; 2022 May; 14(19):1913-1921. PubMed ID: 35522948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fluorescence amplification strategy based on 3D DNA walker and CRISPR/Cas12a for the rapid detection of BRAF V600E.
    Zhang W; Zhao S; Xie Z; Chen S; Huang Y; Zhao Z; Yi G
    Anal Sci; 2022 Aug; 38(8):1057-1066. PubMed ID: 35657565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas14 provides a promising platform in facile and versatile aptasensing with improved sensitivity.
    Zhou B; Yang R; Sohail M; Kong X; Zhang X; Fu N; Li B
    Talanta; 2023 Mar; 254():124120. PubMed ID: 36463799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A universal and sensitive gene mutation detection method based on CRISPR-Cas12a.
    Wang H; Liu R; Dong K; Zhang L; Zhang J; Zhang X; Zhang J; Xiao X; Zhang W; Wang X
    Anal Chim Acta; 2023 Mar; 1246():340886. PubMed ID: 36764772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas12a-based biosensing platform for precise and efficient screening of CRISPR/Cas9-induced biallelic mutants.
    Xiao G; Liu S; Liu H; He X; Zhang S; Liang Z; Guo H; Ou M; Zhou L; Liu L; Zhang T; Zhang G
    Talanta; 2020 Apr; 210():120613. PubMed ID: 31987174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.
    Rössle M; Sigg M; Rüschoff JH; Wild PJ; Moch H; Weber A; Rechsteiner MP
    Virchows Arch; 2013 Nov; 463(5):623-31. PubMed ID: 24085553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CASMART, a one-step CRISPR Cas12a-mediated isothermal amplification for rapid and high-resolution digital detection of rare mutant alleles.
    Zhang C; Cai Z; Zhou Z; Li M; Hong W; Zhou W; Yu D; Wei P; He J; Wang Y; Huang C; Wang X; Wu J
    Biosens Bioelectron; 2023 Feb; 222():114956. PubMed ID: 36525708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the BRAF V600E Mutation in Colorectal Cancer by NIR Spectroscopy in Conjunction with Counter Propagation Artificial Neural Network.
    Zhang X; Yang Y; Wang Y; Fan Q
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31208050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-nucleotide variant of PIK3CA
    Cao G; Chen X; Deng Y; Nie F; Liu Y; Wang G; Huo D; Hou C
    Anal Chim Acta; 2021 Oct; 1182():338943. PubMed ID: 34602188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.
    Affolter K; Samowitz W; Tripp S; Bronner MP
    Genes Chromosomes Cancer; 2013 Aug; 52(8):748-52. PubMed ID: 23650027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of wild-type and V600E mutant BRAF proteins in colorectal carcinoma using immunoenrichment and targeted mass spectrometry.
    Chen H; Hsiao YC; Chiang SF; Wu CC; Lin YT; Liu H; Zhao H; Chen JS; Chang YS; Yu JS
    Anal Chim Acta; 2016 Aug; 933():144-55. PubMed ID: 27497007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature-boosted PAM-less activation of CRISPR-Cas12a combined with selective inhibitors enhances detection of SNVs with VAFs below 0.01.
    Chen K; Dai L; Zhao J; Deng M; Song L; Bai D; Wu Y; Zhou X; Yang Y; Yang S; Zhao L; Chen X; Xie G; Li J
    Talanta; 2023 Aug; 261():124674. PubMed ID: 37201341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
    Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
    BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new microarray substrate for ultra-sensitive genotyping of KRAS and BRAF gene variants in colorectal cancer.
    Galbiati S; Damin F; Pinzani P; Mancini I; Vinci S; Chiari M; Orlando C; Cremonesi L; Ferrari M
    PLoS One; 2013; 8(3):e59939. PubMed ID: 23536897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved detection of BRAF V600E using allele-specific PCR coupled with external and internal controllers.
    Yang Z; Zhao N; Chen D; Wei K; Su N; Huang JF; Xu HQ; Duan GJ; Fu WL; Huang Q
    Sci Rep; 2017 Oct; 7(1):13817. PubMed ID: 29061997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.
    Estrella JS; Tetzlaff MT; Bassett RL; Patel KP; Williams MD; Curry JL; Rashid A; Hamilton SR; Broaddus RR
    Mol Cancer Ther; 2015 Dec; 14(12):2887-95. PubMed ID: 26438153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity.
    Huang H; Huang G; Tan Z; Hu Y; Shan L; Zhou J; Zhang X; Ma S; Lv W; Huang T; Liu Y; Wang D; Zhao X; Lin Y; Rong Z
    BMC Biol; 2022 Apr; 20(1):91. PubMed ID: 35468792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.
    Roma C; Rachiglio AM; Pasquale R; Fenizia F; Iannaccone A; Tatangelo F; Antinolfi G; Parrella P; Graziano P; Sabatino L; Colantuoni V; Botti G; Maiello E; Normanno N
    Cancer Biol Ther; 2016 Aug; 17(8):840-8. PubMed ID: 27261210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF mutation in sporadic colorectal cancer and Lynch syndrome.
    Thiel A; Heinonen M; Kantonen J; Gylling A; Lahtinen L; Korhonen M; Kytölä S; Mecklin JP; Orpana A; Peltomäki P; Ristimäki A
    Virchows Arch; 2013 Nov; 463(5):613-21. PubMed ID: 23963522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.